BlackRock Institutional Trust Company N.A. increased its position in Cantel Medical Corp. (NYSE:CMN) by 19.2% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 1,080,944 shares of the company’s stock after buying an additional 173,741 shares during the period. BlackRock Institutional Trust Company N.A.’s holdings in Cantel Medical Corp. were worth $84,292,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of CMN. Vanguard Group Inc. boosted its position in shares of Cantel Medical Corp. by 3.1% in the second quarter. Vanguard Group Inc. now owns 2,762,913 shares of the company’s stock worth $189,894,000 after buying an additional 84,162 shares in the last quarter. BlackRock Fund Advisors boosted its position in shares of Cantel Medical Corp. by 7.5% in the third quarter. BlackRock Fund Advisors now owns 2,595,572 shares of the company’s stock worth $202,403,000 after buying an additional 180,677 shares in the last quarter. Neuberger Berman Group LLC boosted its position in shares of Cantel Medical Corp. by 11.5% in the third quarter. Neuberger Berman Group LLC now owns 1,061,984 shares of the company’s stock worth $82,814,000 after buying an additional 109,230 shares in the last quarter. New York State Common Retirement Fund boosted its position in shares of Cantel Medical Corp. by 0.4% in the third quarter. New York State Common Retirement Fund now owns 908,253 shares of the company’s stock worth $70,826,000 after buying an additional 3,400 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its position in shares of Cantel Medical Corp. by 497.6% in the third quarter. Wells Fargo & Company MN now owns 803,444 shares of the company’s stock worth $62,652,000 after buying an additional 668,993 shares in the last quarter. Institutional investors own 82.99% of the company’s stock.

Institutional Ownership by Quarter for Cantel Medical Corp. (NYSE:CMN)

Shares of Cantel Medical Corp. (NYSE:CMN) opened at 81.14 on Friday. Cantel Medical Corp. has a 12 month low of $55.01 and a 12 month high of $82.80. The stock’s 50 day moving average price is $75.57 and its 200-day moving average price is $72.84.

The company also recently announced a semiannual dividend, which will be paid on Tuesday, January 31st. Shareholders of record on Tuesday, January 17th will be paid a dividend of $0.07 per share. This is an increase from Cantel Medical Corp.’s previous semiannual dividend of $0.06. This represents a yield of 0.18%. The ex-dividend date is Thursday, January 12th. Cantel Medical Corp.’s payout ratio is 8.33%.

ILLEGAL ACTIVITY NOTICE: This story was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The legal version of this story can be read at http://www.watchlistnews.com/blackrock-institutional-trust-company-n-a-increases-stake-in-cantel-medical-corp-cmn/1061216.html.

Separately, Benchmark Co. reduced their price objective on Cantel Medical Corp. from $100.00 to $83.00 and set a “buy” rating on the stock in a research note on Friday, December 9th.

In other Cantel Medical Corp. news, Chairman Charles M. Diker sold 7,000 shares of the business’s stock in a transaction on Wednesday, October 19th. The shares were sold at an average price of $76.33, for a total transaction of $534,310.00. Following the sale, the chairman now directly owns 3,174,975 shares of the company’s stock, valued at approximately $242,345,841.75. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Chairman Charles M. Diker sold 3,000 shares of the company’s stock in a transaction on Thursday, October 20th. The stock was sold at an average price of $75.61, for a total transaction of $226,830.00. Following the completion of the transaction, the chairman now directly owns 3,171,270 shares in the company, valued at $239,779,724.70. The disclosure for this sale can be found here. Company insiders own 14.90% of the company’s stock.

About Cantel Medical Corp.

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

5 Day Chart for NYSE:CMN

Want to see what other hedge funds are holding CMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMN).

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.